Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension
Status:
WITHDRAWN
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess precision dosing of amlodipine to deliver reductions in blood pressure in patients with primary hypertension and inadequate BP control by up-titration of amlodipine in 1mg increments